Scegli un formato
438,00 €
438,00 €
Informazioni su questo articolo
Vai a
Nome del prodotto
Anti-IGF-I Antibody, clone Sm1.2, clone Sm1.2, Upstate®, from mouse
biological source
mouse
conjugate
unconjugated
antibody form
purified immunoglobulin
clone
Sm1.2, monoclonal
species reactivity
avian, chicken, mouse, rat, human
manufacturer/tradename
Upstate®
technique(s)
immunohistochemistry: suitable
immunoprecipitation (IP): suitable
neutralization: suitable
western blot: suitable
isotype
IgG1κ
NCBI accession no.
UniProt accession no.
shipped in
dry ice
target post-translational modification
unmodified
Quality Level
Gene Information
human ... IGF1(3479)
1 of 4
Questo articolo | 05-172-AF488 | 06-429-I | 05-1571 |
|---|---|---|---|
| biological source mouse | biological source mouse | biological source chicken | biological source mouse |
| clone Sm1.2, monoclonal | clone Sm1.2, monoclonal | clone polyclonal | clone 24-57, monoclonal |
| antibody form purified immunoglobulin | antibody form purified antibody | antibody form purified immunoglobulin | antibody form purified immunoglobulin |
| species reactivity avian, chicken, mouse, rat, human | species reactivity chicken, rat, mouse, human, fish | species reactivity human | species reactivity human |
| shipped in dry ice | shipped in wet ice | shipped in wet ice | shipped in wet ice |
| Gene Information human ... IGF1(3479) | Gene Information human ... IGF1(3479) | Gene Information human ... IGF1R(3480) | Gene Information human ... IGF1R(3480) |
Analysis Note
MCF-7 cell extracts
Western Blot Analysis:
0.5-2 μg/mL of this antibody detected 100 ng of IGF-I (Catalog # 01-208) under non-reducing conditions.
Application
5 μg of a previous lot immunoprecipitated 100 ng of IGF-I.
Immunohistochemistry:
10 μg/mL of a previous lot was reported by an independent laboratory to detect IFG-I in formalin-fixed, paraffin-embedded skin sections.
(Lui, 1994).
Neutralization:
10-20 μg/mL of a previous lot inhibited the activity of 10 ng/mL of IGF-I as determined by testing with chicken embryo fibroblasts (CEF) using an ATP endpoint assay (ATPLiteTM-M, Packard Instruments).
Signaling
Insulin/Energy Signaling
Biochem/physiol Actions
Disclaimer
General description
IGF-1 is produced primarily by the liver as an endocrine hormone and targets tissues in a paracrine/autocrine fashion. Production is stimulated by growth hormone and can be retarded by undernutrition, growth hormone insensitivity, lack of growth hormone receptors, or failures of the downstream signaling pathway post GH receptor including SHP2 and STAT5b. Approximately 98% of IGF-1 is always bound to one of 6 binding proteins (IGF-BP). IGFBP-3, the most abundant protein, accounts for 80% of all IGF binding. IGF-1 binds to IGFBP-3 in a 1:1 molar ratio. Its primary action is mediated by binding to specific IGF receptors present on many cell types in many tissues. The signal is transduced by intracellular events. IGF-1 is one of the most potent natural activators of the AKT signaling pathway, a stimulator of cell growth and multiplication and a potent inhibitor of programmed cell death.
Immunogen
Other Notes
Physical form
Preparation Note
Legal Information
Classe di stoccaggio
11 - Combustible Solids
wgk
WGK 1
Certificati d'analisi (COA)
Cerca il Certificati d'analisi (COA) digitando il numero di lotto/batch corrispondente. I numeri di lotto o di batch sono stampati sull'etichetta dei prodotti dopo la parola ‘Lotto’ o ‘Batch’.
Possiedi già questo prodotto?
I documenti relativi ai prodotti acquistati recentemente sono disponibili nell’Archivio dei documenti.
Filtri attivi
Il team dei nostri ricercatori vanta grande esperienza in tutte le aree della ricerca quali Life Science, scienza dei materiali, sintesi chimica, cromatografia, discipline analitiche, ecc..
Contatta l'Assistenza Tecnica


